- Home
- ENB vs GSK Comparison
ENB vs GSK Comparison
Compare ENB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENB | GSK |
|---|---|---|
| Founded | 1949 | 1715 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.2B | 96.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ENB | GSK |
|---|---|---|
| Price | $50.16 | $60.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $63.00 | N/A |
| AVG Volume (30 Days) | 5.0M | ★ 6.1M |
| Earning Date | 02-13-2026 | 02-04-2026 |
| Dividend Yield | ★ 5.35% | 2.78% |
| EPS Growth | N/A | ★ 123.15 |
| EPS | 1.84 | ★ 1.87 |
| Revenue | ★ $46,115,630,085.00 | $43,966,352,618.00 |
| Revenue This Year | $16.21 | $7.72 |
| Revenue Next Year | N/A | $4.59 |
| P/E Ratio | $27.43 | ★ $15.60 |
| Revenue Growth | ★ 32.29 | 4.12 |
| 52 Week Low | $39.73 | $32.38 |
| 52 Week High | $50.95 | $60.37 |
Technical Indicators
Market Signals| Indicator | ENB | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 70.01 | 82.82 |
| Support Level | $47.96 | $49.60 |
| Resistance Level | $49.30 | $59.62 |
| Average True Range (ATR) | 0.76 | 0.79 |
| MACD | 0.33 | 1.02 |
| Stochastic Oscillator | 97.08 | 97.12 |
Price Performance
Historical ComparisonAbout ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.